Streetbeat News

Regulatory

MURA

Mural Oncology is set to host a Virtual Investor Day to discuss new clinical insights into their late-stage trials of nemvaleukin, with key data readouts expected in 2025. An IND submission for their IL-18 program is planned for Q4 2025.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:20 am

EYEN

Eyenovia has launched and made commercially available Clobetasol Propionate Ophthalmic Suspension 0.05% in the US. This FDA-approved treatment is for post-operative inflammation and pain following ocular surgery.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:12 am

ANIP

ANI Pharmaceuticals has received FDA approval for its generic version of Ketoconazole Shampoo, 2%, which is a generic version of Nizoral. The U.S. annual sales for this product are approximately $69.2 million.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:53 am

NNVC

NanoViricides, Inc. has secured a right of first refusal for all antiviral drug developments from TheraCour Pharma, enhancing its ability to develop broad-spectrum antiviral drugs. The company plans to advance its lead drug, NV-387, to Phase II trials.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:36 am

AXNX

The Australian Therapeutic Goods Administration has approved Axonics' R20 Rechargeable Sacral Neuromodulation System for marketing. Axonics plans to start sales in Australia in November, targeting overactive bladder and fecal incontinence treatments.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:05 am

ZM

Zoom CEO Eric Yuan predicts AI will enable four-day work weeks within 20 years, aligning with views of industry leaders like Bill Gates and Steve Cohen. Zoom is investing in AI to create digital twins for routine tasks, though Yuan stresses the need for cautious AI deployment.

Portfolio Pulse from Benzinga Neuro

September 26, 2024 | 9:48 am

GEV

GE Vernova Inc. has been selected by the U.S. Department of Energy to lead a project focused on developing AI tools for permitting and safety in hydrogen deployment. The project, named 'H2Net', involves collaboration with Clemson University and Roper Mountain Science Center, and is valued at $1 million in federal funding.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 9:47 am

STLA

Stellantis is recalling nearly 16,000 Fiat 124 Spider vehicles in the US due to concerns over improper airbag deployment. The issue affects models from 2017 to 2020, with a solution expected by Q4 2024.

Portfolio Pulse from Anan Ashraf

September 26, 2024 | 8:42 am

TIP

Analyst Gordon Johnson challenges Transportation Secretary Pete Buttigieg's claim that inflation decreased after the Inflation Reduction Act of 2022. Johnson argues that inflation is still rising, albeit at a slower pace. Economist Peter Schiff also criticizes the Act, suggesting it could lead to higher inflation due to government spending. The iShares TIPS Bond ETF, which tracks inflation-protected U.S. Treasury bonds, saw a slight decline.

Portfolio Pulse from Shanthi Rexaline

September 26, 2024 | 8:20 am